Following an assessment1 of the core strategies of HITAP carried out by a team of Thai and UK investigators in 2007-2008, at the request of the Thai Health Promotion Foundation, HITAP has initiated a second evaluation, in 2011, this time bringing together a team of UK, Thai and Korean assessors. These recommendations were the result of data analysi

11-303-2555(9)inborn errors,การตรวจกรอง

The Union of Myanmar is the largest country in mainland South-East Asia with a population of 57.5 million. It has a pluralistic mix of public and private healthcare systems. Although the Ministry of Health (MoH) is the main organisation responsible for healthcare provision, 70-80% of health service expenditure is now absorbed by the households. Thi

17-207-2555Senior Research Scholar Program,Thailand Research Fund,TRF

20-208-2556collaboration project,Philippines,ความร่วมมือ

Objective: This study aims to assess the cost-utility of providing either trivalent live-attenuated influenza vaccine (LAIV) or trivalent inactivated influenza vaccine (TIV) to school-aged children to prevent seasonal influenza. Methods: A deterministic age-structured dynamic transmission model was constructed and used to evaluate economic conse

Introduction: The development of new technology to treat patients with metastatic renal cell carcinoma has resulted in promising outcomes in terms of extending life and improving quality of life. In Thailand, where health resources are limited, an economic evaluation of such technology would provide useful information for pricing and reimbursement